Page 227 of Covid-19

According to the Indian Council of Medical Research (ICMR), 25,52,14,803 samples have so far been tested in the country for…

India should have reported 320 cases of blood clot associated with administering of Covishield vaccine by now if the European…

Developed by Oxford University and Swedish-British pharma major AstraZeneca, Covishield is being manufactured by SII.

Most experts have maintained that getting as many people inoculated as possible is the only defense available under the current…

With an average of 34,30,502 anti-coronavirus doses being given per day, India has topped globally in terms of the number…

Eight months after mild COVID-19, one in ten people experience at least one moderate to severe symptom that is perceived…

India is once again seeing a daily surge in COVID-19 cases with five most affected states being Maharashtra (3,057,885), Kerala…

The Centre wrote to Maharashtra, Punjab and Delhi governments on Wednesday flagging below-par vaccination of eligible beneficiaries, including healthcare workers.

EU drug regulator finds ‘possible link’ between AstraZeneca vaccine and rare clots; says benefits still outweigh risks. 

Health Secretary Rajesh Bhushan in a letter to the chief secretaries said a substantial proportion of population aged 45 years…